Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: Integrative Neuro-social Cognitive Strategy Programme for Instilling REcovery (INSPIRE) a Community-Based Cognitive Remediation Trial [NA]
INSPIRE is a community-based cognitive remediation trial for schizophrenia and schizoaffective disorder, currently recruiting in Singapore.
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: Deep Brain Stimulation of the Nucleus Accumbens and Anterior Limb of the Internal Capsule in the Treatment of Refractory Schizophrenia [NA]
A clinical trial is evaluating deep brain stimulation of the nucleus accumbens and anterior limb of the internal capsule for treatment of re…
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: Berberine in Treating Negative Symptoms of Schizophrenia: Clinical Efficacy and Mechanisms [NA]
Berberine is being studied for negative symptoms of schizophrenia, with the trial currently enrolling by invitation and no phase specified.
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Gamma Light and Sound Stimulation in Schizophrenia [NA]
MIT-led clinical trial is investigating gamma light and sound stimulation as a treatment for schizophrenia spectrum disorders; the study is …
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: SloMo2: Implementation, Effectiveness, and Cost-effectiveness Study [NA]
Clinical trial update for SloMo2 describes an implementation, effectiveness, and cost-effectiveness study in schizophrenia and affective psy…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Family-Focused Therapy for Individuals at High Clinical Risk for Psychosis: A Confirmatory Efficacy Trial [NA]
A confirmatory efficacy trial of Family-Focused Therapy for individuals at high clinical risk for psychosis is ongoing, sponsored by the Uni…
-
CLINICAL_TRIALS trial_result · 2026-01-26Clinical Trial Update: Open-label Trial Characterizing the PK of 3 SC Olanzapine Extended-release Formulations in Participants With Schizophrenia/Schizoaffective Disorder [Phase 1]
An open-label Phase 1 study evaluated the pharmacokinetics of three subcutaneous extended-release olanzapine formulations in adults with sch…
-
CLINICAL_TRIALS trial_result · 2026-01-26Clinical Trial Update: Effect of Psychoeducation -Based Motivational Interviewing on Knowledge and Hope in Schizophrenia [NA]
A completed clinical trial evaluating psychoeducation-based motivational interviewing to improve knowledge and hope in people with schizophr…
-
FDA approval · 2026-01-26FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Original Application (Novadoz Pharmaceuticals LLC)
FDA approved the original application for chlorpromazine hydrochloride, with Novadoz Pharmaceuticals LLC listed as the applicant.
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Dimensional and Developmental Profiles of Psychosis in Children and Adolescents [NA]
A clinical trial studying dimensional and developmental profiles of psychosis in children and adolescents. The study is currently recruiting…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: European Long-acting Antipsychotics in Schizophrenia Trial-II
Clinical trial update for European long-acting antipsychotics in schizophrenia (Trial II) is currently enrolling by invitation.
-
EMA approval · 2026-01-23EMA Authorised: Aripiprazole Mylan Pharma (previously Aripiprazole Pharmathen) (aripiprazole) — Mylan Pharmaceuticals Limited
EMA authorised Aripiprazole Mylan Pharma (generic aripiprazole) for schizophrenia and bipolar disorder.
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Randomized Clinical Trial of iTEST: A Blended Intervention Targeting Introspective Accuracy [NA]
A randomized clinical trial of iTEST, a blended intervention targeting introspective accuracy, is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial [Phase 4]
A Phase 4 randomized trial evaluating clozapine for reducing violence in people with schizophrenia or schizoaffective disorder; the study is…
-
FDA approval · 2026-01-22FDA Approved: OLANZAPINE — Supplemental Application (Modavar Pharmaceuticals LLC)
The FDA approved Modavar Pharmaceuticals LLC's supplemental application to market a generic olanzapine product.
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: The Acupuncture Treatment Effect in Patients With Schizophrenia [NA]
A clinical trial update for a study on acupuncture treatment in patients with schizophrenia, sponsored by Calo Psychiatric Center; the trial…
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: Berberine Improving Cognitive Impairments in Schizophrenia [NA]
Ongoing clinical trial in China evaluating whether berberine improves cognitive impairments associated with schizophrenia, sponsored by Tian…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Using Transcranial Magnetic Stimulation (TMS) to Understand Hallucinations in Schizophrenia [NA]
A recruiting clinical trial at McLean Hospital is using transcranial magnetic stimulation to study hallucinations in schizophrenia and schiz…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: rTMS for Depressive, Positive and Negative Symptoms, and Physiological Indices of Schizophrenia Patients [NA]
A ClinicalTrials.gov study from National Taiwan University Hospital is evaluating repetitive transcranial magnetic stimulation (rTMS) for de…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Multimodal Physical Exercise Program (Physical Exercise for Psychosis) for People With Psychosis Treated With Long-Acting Injectable Antipsychotics [NA]
A clinical trial update shows a multimodal physical exercise program for people with psychosis treated with long-acting injectable antipsych…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure [Phase 3]
This Phase 3 clinical trial is recruiting to test intensified pharmacological treatment for schizophrenia, major depressive disorder, and bi…
-
CLINICAL_TRIALS trial_result · 2026-01-20Clinical Trial Update: A Pharmaco-imaging Approach to Predicting Social Functioning and Clinical Responses to Oxytocin Administration in Schizophrenia [Phase 2]
This Phase 2 trial investigated oxytocin's effects in schizophrenia using pharmaco-imaging to predict social functioning and clinical respon…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Cognitive Behavioral Therapy for Sleep and Circadian Disturbances (CBT-I) in Treatment-Resistant Schizophrenia [NA]
A clinical trial evaluating Cognitive Behavioral Therapy for Sleep and Circadian Disturbances (CBT-I) in individuals with treatment-resistan…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Biomarkers in Clozapine-responding Schizophrenia [Phase 4]
A Phase 4 clinical trial update investigating biomarkers in clozapine-responsive schizophrenia, with recruitment currently ongoing.
-
FDA approval · 2026-01-16FDA Approved: RYKINDO EXTENDED-RELEASE MICROSPHERES — Supplemental Application (Shandong Luye Pharmaceutical Co., Ltd.)
FDA approved a supplemental application for RyKindo Extended-Release Microspheres, a new extended-release formulation of risperidone develop…